Navigation Links
Compendia Bioscience Announces the Release of Oncomine 4 Research Edition
Date:9/23/2009

ANN ARBOR, Mich., Sept. 23 /PRNewswire-USNewswire/ -- Compendia Bioscience, Inc. today announced the release of Oncomine Research Edition version 4.2, a significant product upgrade for the academic and non-profit communities. Since its inception, Compendia has been fully committed to supporting academic and non-profit cancer research efforts worldwide. This new version of Oncomine features a completely redesigned user-interface, improved search and filter capabilities, and several other new features designed to make gene discovery and validation simpler and more efficient.

Cancer researchers have made Oncomine the industry standard with over 12,000 academic users. These researchers use Oncomine to discover new genes, evaluate pathways and better understand specific cancer types resulting in the publication of more than 200 peer reviewed journal articles. Oncomine has led to several major cancer research discoveries such as the recent publication of AGTR1 overexpression and sensitivity to losartan in breast cancer (Proc Natl Acad Sci U S A. 2009 Jun 1).

"We are really pleased to release this exciting new version of Oncomine to the academic research community," said Compendia's Co-Founder and CEO Dan Rhodes, Ph.D. "We are confident that Oncomine 4 will continue to accelerate cancer research and lead to important new discoveries."

New Features and Capabilities in Oncomine 4 Research Edition

  • Unified interface, optimizing workflows with rapid navigation and visualization of results through three interactive panes
  • Smart search and browse, giving users the ability to search multiple terms within a single instance
  • The Compendia Ontology, standardizing a set of rules used to characterize Oncomine data, which drives consistent downstream analyses
  • Standardized analyses, comparing gene expression profiles between norma
    '/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Compendia Bioscience Announces the Receipt of a $2.4M SBIR Award and Related Management Changes
2. Compendia Bioscience Announces the Release and Availability of Oncomine(TM) Research Premium Edition
3. GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
4. On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
7. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
8. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
10. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 The Microcompetition with ... major disease. One of these latent viruses is the Epstein ... arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... a study found that RA patients have high concentrations of ...
(Date:1/15/2014)... 15, 2014 AudioNotch is the internet's ... for the treatment of tinnitus. Patients listen to sound ... over a period of weeks to months, their tinnitus volume ... two forms: Notched Music and Notched White Noise. Now, AudioNotch ...
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that ... company update at the Deutsche Bank 34th Annual Health Care ... p.m. ET. Interested parties may access a live audio ... the BioMarin website, www.BMRN.com . A ...
... platform for treatment of Spinal Muscular Atrophy SOUTH PLAINFIELD, ... Inc. (PTC) and the Spinal Muscular Atrophy (SMA) Foundation ... which the SMA Foundation will provide up to $8.5 ... second continuation of the collaboration to fund a series ...
... AND STRENGTHENS ITS SENIOR MANAGEMENT TEAM , ... Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in ... today announced that it has strengthened its European presence ... Summa. As Executive Vice President, Europe & Asia/Pacific based ...
Cached Biology Technology:BioMarin to Present at the Deutsche Bank Health Care Conference 2PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 2PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 3OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific 2OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific 3
(Date:7/10/2014)... and teens living with a cardiac pacemaker, a low ... of life, reports a study in the July ... the official journal of the Society for Developmental ... by Lippincott Williams & Wilkins , a part ... function as a protective factor against lower health-related quality ...
(Date:7/10/2014)... image was collected by the Moderate Resolution Imaging Spectroradiometer ... Each hot spot, which appears as a red mark, ... MODIS instrument recognized temperatures higher than background. When accompanied ... hot spots are diagnostic for fire. , This ... coming directly from the fires, although the smoke released ...
(Date:7/10/2014)... some patients, the chronic inflammatory skin diseases psoriasis* and ... have therefore had to base their decision on which ... an examination of tissue samples. A team of researchers ... of Munich (TUM) have now analyzed the molecular processes ... This has enabled them for the first time to ...
Breaking Biology News(10 mins):For children with pacemakers, 'self-competence' affects quality of life 2New diagnostic test to distinguish psoriasis from eczema 2
... Science-based identification of mold and other causes of ... plant pathologists with The American Phytopathological Society (APS). ... situation in which building occupants experience health problems ... typically associated with SBS range from allergy attacks ...
... South Korean team announced last week that it had ... that were genetically matched to specific people. But their ... Yuri Verlinsky of the Reproductive Genetics Institute, based in ... without resorting to therapeutic cloning. "It would be a ...
... When genes are deleted on a particular section of ... the childhood cancer neuroblastoma. A new study suggests that ... children with neuroblastoma may indicate to physicians that they ... fight the cancer. , Edward F. Attiyeh, M.D., a ...
Cached Biology News:What's really making you sick? Plant pathologists offer the science behind Sick Building Syndrome 2Double triumph in stem cell quest 2Double triumph in stem cell quest 3Double triumph in stem cell quest 4Chromosome Deletion Predicts Aggressive Neuroblastoma 2
... Glutathion-S-Transferase-pi EIA Principle: Glutathion-S-transferases ... which are involved in the detoxification ... 5 subgroups: Alpha, Mu, Pi, Teta ... their physiochemical, immunological, enzymatic and s ...
... only microplate sealer with an integrated in-line ... with a variety of configurations and sealing ... integrated stacker and 240-plate storage capacity , ... in small workcells , Handles all SBS ...
... aptamer screening and binding optimization and built ... on-chip synthesis platform. These microarrays are available ... Microarray Service. Probe Content ... than 1500 known aptamer sequences. Add up ...
... Microarrays designed for RNA aptamer screening and ... and powerful Paraflo microfluidic on-chip synthesis platform. ... be synthesized on-chip and LC Sciences can ... microarrays are available as part of our ...
Biology Products: